Cytori Therapeutics, Inc. (CYTX) At $0.38 Forms Bottom; Sierra Bancorp (BSRR) Sentiment Is 1.71

January 12, 2018 - By Maria Brooks

Sierra Bancorp operates as the bank holding firm for Bank of the Sierra that provides a range of retail and commercial banking services to individuals and businesses in California. The company has market cap of $422.32 million. The firm accepts various deposit products, such as checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, sweep accounts, demand deposit accounts, NOW accounts, certificates of deposit, and brokered deposits. It has a 18.4 P/E ratio. It also provides real estate loans secured by commercial, professional office, and agricultural properties; construction loans for residential and commercial development; permanent mortgage loans, land acquisition and development loans, and multifamily credit facilities; secondary market services for residential mortgage loans; agricultural production loans; commercial and industrial loans and leases, including SBA loans and direct finance leases; mortgage warehouse loans; and consumer loans.

Cytori Therapeutics, Inc. (CYTX) formed multiple bottom with $0.37 target or 3.00% below today’s $0.38 share price. Cytori Therapeutics, Inc. (CYTX) has $13.17 million valuation. The stock decreased 1.47% or $0.01 during the last trading session, reaching $0.38. About 512,293 shares traded. Cytori Therapeutics, Inc. (NASDAQ:CYTX) has declined 65.60% since January 12, 2017 and is downtrending. It has underperformed by 82.30% the S&P500.




Analysts await Sierra Bancorp (NASDAQ:BSRR) to report earnings on January, 22. They expect $0.42 EPS, up 5.00% or $0.02 from last year’s $0.4 per share. BSRR’s profit will be $6.39M for 16.52 P/E if the $0.42 EPS becomes a reality. After $0.41 actual EPS reported by Sierra Bancorp for the previous quarter, Wall Street now forecasts 2.44% EPS growth.

Private Management Group Inc holds 0.62% of its portfolio in Sierra Bancorp for 429,247 shares. Banc Funds Co Llc owns 445,312 shares or 0.54% of their US portfolio. Moreover, Foundry Partners Llc has 0.2% invested in the company for 180,065 shares. The United Kingdom-based Gsa Capital Partners Llp has invested 0.05% in the stock. Numeric Investors Llc, a Massachusetts-based fund reported 252,801 shares.

The stock increased 0.76% or $0.21 during the last trading session, reaching $27.75. About 1,219 shares traded. Sierra Bancorp (BSRR) has risen 40.79% since January 12, 2017 and is uptrending. It has outperformed by 24.09% the S&P500.

Since January 1, 0001, it had 0 buys, and 1 sale for $53,000 activity.

Among 6 analysts covering Cytori Therapeutics (NASDAQ:CYTX), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Cytori Therapeutics has $1000 highest and $0.5 lowest target. $3.35’s average target is 781.58% above currents $0.38 stock price. Cytori Therapeutics had 11 analyst reports since August 8, 2015 according to SRatingsIntel. Maxim Group maintained Cytori Therapeutics, Inc. (NASDAQ:CYTX) on Monday, July 24 with “Buy” rating. Maxim Group maintained Cytori Therapeutics, Inc. (NASDAQ:CYTX) on Saturday, August 8 with “Buy” rating. The stock of Cytori Therapeutics, Inc. (NASDAQ:CYTX) has “Buy” rating given on Wednesday, May 31 by Maxim Group. B. Riley & Co downgraded Cytori Therapeutics, Inc. (NASDAQ:CYTX) on Tuesday, July 25 to “Neutral” rating. The firm has “Hold” rating given on Friday, September 4 by Zacks. The firm has “Buy” rating given on Friday, August 11 by Maxim Group. TH Capital maintained it with “Buy” rating and $4.0 target in Monday, August 10 report. As per Monday, July 10, the company rating was maintained by Maxim Group.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts